Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.
The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio.
The deal was first announced in February, and Nevro was valued at $250 million. Nevro employs HFX spinal cord stimulation, which is used in its Senza SCS system. The company also offers minimally invasive treatments for chronic sacroiliac joint pain.
